PDF herunterladen
Vet Comp Orthop Traumatol 2005; 18(03): 169-174
DOI: 10.1055/s-0038-1632949
Original Research
Schattauer GmbH

Examination of synovial fluid and serum following intravenous injections of hyaluronan for the treatment of osteoarthritis in dogs

S. O. Canapp
1   Department of Orthopedic Surgery and Sports Medicine, VCA Veterinary Referral Associates, Gaithersburg, Maryland, USA
,
A. R. Cross
2   Georgia Veterinary Specialists, Atlanta, Georgia, USA
,
M. P. Brown
3   Departments of Large Animal Clinical Sciences
,
D. D. Lewis
4   Small Animal Clinical Sciences and the Center for Veterinary Sports Medicine, College of Veterinary Medicine
,
J. Hernandez
3   Departments of Large Animal Clinical Sciences
,
K. A. Merritt
3   Departments of Large Animal Clinical Sciences
,
R. Tran-Son-Tay D. Sc
5   Department of Mechanical and Aerospace Engineering, College of Engineering, University of Florida, Gainesville, Florida, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 16. September 2004

Accepted 25. März 2005

Publikationsdatum:
22. Februar 2018 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Summary

A randomized, blinded, prospective clinical trial was performed to determine the effects of intravenous (IV) administration of hyaluronan sodium (HA) on serum glycosaminoglycans (GAG) concentrations, synovial fluid (SF) hyaluronan concentrations and viscosity in dogs treated for unilateral rupture of the cranial cruciate ligament. Twenty-two dogs undergoing tibial plateau leveling osteotomy were used in this study. Synovial fluid from both stifles and serum were collected prior to surgery and at 2, 4, and 8 weeks following surgery. Dogs received either 1.0 ml (10 mg) of sodium hyaluronate (treatment group 1; n = 10) or equal volume of 0.9% NaCl (treatment group 2; n = 12), IV immediately, 2 and 4 weeks following surgery. Synovial fluid viscosity was evaluated using a magnetically driven, acoustically tracked, translating-ball rheometer. Synovial fluid HA disaccharide content was measured by fluorophore-assisted carbohydrate electrophoresis. Serum GAG concentrations were measured by alcian blue spectrophotometric assay. Data were analyzed using a Wilcoxon sign rank test (p<0.05). Mean ± SD viscosity (cP) was significantly higher (p=0.011) in SF obtained from the intact stifle (450 ± 604.1) than injured (54.8 ± 60.8) prior to surgery. Mean ± SD HA concentrations (ug/ml) were significantly higher (p=0.02) in synovial fluid obtained from the injured stifles (281.4 ± 145.9) than intact stifles (141.6 ± 132.5). No significant difference was noted within or between treatment groups in SF viscosity, HA concentrations, or serum GAG concentrations at any time following surgery. Stifles with cranial cruciate ligament insufficiency had significant alterations in SF viscosity and HA concentrations.

Keywords

Hyaluronic acid - synovial fluid - osteoarthritis
 

  • References

  • 1 Abatangelo G. et al. Intraarticular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. Biochemical results. Clin Orthop 1989; 241: 278-85.
    PubMedSuche in Google Scholar
  • 2 Altman RD. et al. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee:arandomized clinical trial. Hyalgan study group. J Rheumatol 1998; 25: 2203-12.
    PubMedSuche in Google Scholar
  • 3 Arican M. et al. Hyaluronan in canine arthropathies. JComp Pathol 1994; 111: 185-95.
    PubMedSuche in Google Scholar
  • 4 Balazs EA. et al. Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritic human fluids. Arthritis Rheum 1967; 10: 357.
    PubMedSuche in Google Scholar
  • 5 Beaty N. et al. Relative molecular weight and concentration determination of sodium hyaluronate solutions by gel-exclusion high-performance liquid chromatography. Anal Biochem 1985; 147: 387-95.
    CrossrefPubMedSuche in Google Scholar
  • 6 Bjornsson S. Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue. Anal Biochem 1993; 210: 282-91.
    CrossrefPubMedSuche in Google Scholar
  • 7 Brown M. et al. Fluorophore-assisted carbohydrate electrophoresis (FACE) analysis of chondroitin sulphate and keratan sulphate in synovial fluid. Proceedings 49th Ann Meet Orthop Res Soc. 2003
    PubMedSuche in Google Scholar
  • 8 Canapp S. et al. Serologic levels of hyaluronan, osteocalcin, and collagen 2 % in normal dogs and dogs with synovitis. Proceedings 10th AnnAm Col Vet Surg Symp 4. 2000
    PubMedSuche in Google Scholar
  • 9 Dahl LB. et al. Concentration and molecular weight of sodium hyaluronic in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985; 44: 817.
    CrossrefPubMedSuche in Google Scholar
  • 10 Dejardan LM. Tibial Plateau Leveling Procedures. Proceedings 12th Ann Am Col Vet Surg Symp 328. 2002
    PubMedSuche in Google Scholar
  • 11 Frizziero L. et al. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheumatol 1998; 16: 441-9.
    PubMedSuche in Google Scholar
  • 12 Gaustad G. et al. Comparison of polysulphated glycosaminoglycan and sodium hyaluronate with placebo in treatment of traumatic arthritis in horses. Equine Vet J 1995; 27: 356-62.
    CrossrefPubMedSuche in Google Scholar
  • 13 Gosh P. The role of hyaluronic acid (hyaluronan) in health and disease: interactions with cells, cartilage and components of the synovial fluid. Clin Exp Rheumatol 1994; 12: 75-82.
    PubMedSuche in Google Scholar
  • 14 Gosh P. et al. The effects of intraarticular administration of hyaluronan in amodel of early osteoarthritis in sheep. Gait analysis and radiological and morphological studies. Semin Arthritis Rheum 1993; 22 (suppl) 18-30.
    PubMedSuche in Google Scholar
  • 15 Hasselbacher P. Measuring synovial fluid viscosity with a white blood cell diluting pipette. Arthritis Rheum 1976; 19: 1358-62.
    CrossrefPubMedSuche in Google Scholar
  • 16 Hilbert BJ. et al. Hyaluronic acid concentration in synovial fluid fromnormal and arthritic joints of horses. Aust Vet J 1984; 61: 22-5.
    CrossrefPubMedSuche in Google Scholar
  • 17 Hilbert BJ. et al. Changes in the synovia after the intra-articular injection of sodium hyaluronate into normal horse joints and after arthrotomy and experimental cartilage damage. Aust Vet J 1985; 62: 182-4.
    CrossrefPubMedSuche in Google Scholar
  • 18 Hollander JL. et al. Examination of synovial fluid as a diagnostic aid in arthritis. Med Clin North Am 1966; 50: 1281-39.
    CrossrefPubMedSuche in Google Scholar
  • 19 Howard RD. et al. Hyaluronan and its use in the treatment of equine joint disease. In: Mcllwraith WC, Trotter GW. Joint Disease in the Horse. W.B. Saunders Company; 1996: 257-69.
    Suche in Google Scholar
  • 20 Huskisson EC. et al. Hyaluronic acid in the treatment of osteoarthritis of the knee. J Rheumatol 1999; 38: 602-7.
    CrossrefPubMedSuche in Google Scholar
  • 21 Iwata H. Pharmacologic and clinical aspects of intraarticular injection of hyaluronate. Clin Orthop 1993; 289-5.
    PubMedSuche in Google Scholar
  • 22 Kawasaki K. et al. Hyaluronic acid enhances proliferation and chondroitin sulphate synthesis in cultured chondrocyte embedded in collagen gels. J Cell Physiol 1999; 179: 142-8.
    CrossrefPubMedSuche in Google Scholar
  • 23 Kawcak CE. et al. Effect of intravenous administration of sodium hyaluronate on carpal joints in exercising horses after arthroscopic surgery and osteochondral fragmentation. Am J Vet Res 1997; 58: 1132-40.
    PubMedSuche in Google Scholar
  • 24 Kobayashi K. The long term effects of hyaluronan during development of osteoarthritis following partial menisectomy in a rabbit model. Osteoarthritis Cartilage 2000; 8: 359-65.
    CrossrefPubMedSuche in Google Scholar
  • 25 Kongtawelert P. et al. An enzyme-linked immunosorbent-inhibition assay for quantitation of hyaluronan (Hyaluronic acid) in biological fluids. Anal Bioch 1989; 178: 367-72.
    CrossrefPubMedSuche in Google Scholar
  • 26 Kuroki K. et al. Mechanisms of action and potential uses of hyaluronan in dogs with osteoarthritis. J Am Vet Med Assoc 2002; 221: 944-50.
    CrossrefPubMedSuche in Google Scholar
  • 27 Larkin J. et al. The correlation of clinical assessment of synovial fluid with its measured viscosity. Br J Rheumatol 1984; 23: 195-7.
    CrossrefPubMedSuche in Google Scholar
  • 28 Larsen NE. et al. Effect of hylan on cartilage and chondrocyte cultures. J Orthop Res 1992; 10: 23-32.
    CrossrefPubMedSuche in Google Scholar
  • 29 Lussier A. et al. Viscosupplementation with hylan for the treatment of osteoarthitis: findings from clinical practice in Can. J Rheumatol 1996; 23: 1579-85.
    PubMedSuche in Google Scholar
  • 30 Marshall KW. et al. Amelioration of disease severity by intraarticular Hylan therapy in bilateral canine osteoarthritis. J Orthop Res 2000; 18: 416-25.
    CrossrefPubMedSuche in Google Scholar
  • 31 Mcllwraith CW. Diseases of joints, tendons, ligaments and related structures. In: Stashak TS. ed Adams' Lameness in Horses. Philadelphia, Pa: Lea & Febiger; 1984: 368-9.
    Suche in Google Scholar
  • 32 Mensitieri M. et al. Viscoelastic evaluation of different knee osteoarthritis therapies. J Rheumatol 1995; 130-7.
    PubMedSuche in Google Scholar
  • 33 Morris EA. et al. Inhibition of interleukin 1mediated proteoglycan degradation in bovine articular cartilage explants by addition of sodium hyaluronate. Am J Vet Res 1992; 53: 1977-82.
    PubMedSuche in Google Scholar
  • 34 Calabro A. et al. Fluorophore-assisted carbohydrate electrophoresis (FACE) of glycosaminoglycans. Osteoarthritis Cartilage 2001; 9 Suppl A S16-22.
    PubMedSuche in Google Scholar
  • 35 Peyron J. Intraarticular hyaluronan injections in the treatment of osteoarthritis: state-of-the-art review. J Rheumatol 1993; 20 (suppl 39) 10-5.
    PubMedSuche in Google Scholar
  • 36 Presti D. et al. Hyaluronan mediated protective effect against cell damage caused by enzymatically generated hydroxyl radicals is dependent on hyaluronan molecular mass. Cell Biochem Funct 1994; 12: 281-8.
    CrossrefPubMedSuche in Google Scholar
  • 37 Ropes MW. et al. Diagnostic criteria for rheumatoid arthritis-1958 revision. Ann Rheum Dis 1959; 18: 49-53.
    CrossrefPubMedSuche in Google Scholar
  • 38 Sakakibara Y. et al. Effect of high-molecular weight sodium hyaluronate on immobilized rabbit knee. Clin Orthop 1994; 229: 282-92.
    PubMedSuche in Google Scholar
  • 39 Schiavinato A. et al. Intraarticular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis on dogs. Morphological findings. Clin Orthop 1989; 241: 286-99.
    PubMedSuche in Google Scholar
  • 40 Sharif M. et al. Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 1995; 38: 760-7.
    CrossrefPubMedSuche in Google Scholar
  • 41 Shimazu A. et al. Effects of hyaluronic acid on the release of proteoglycan from cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokines. Arthritis Rheum 1993; 36: 247-53.
    CrossrefPubMedSuche in Google Scholar
  • 42 Smith GN. et al. Effect of intraarticular HA injection on the synovial fluid of OA joints. Proceedings 46th Ann Meet Orthop Res Soc. 2000: 233.
    PubMedSuche in Google Scholar
  • 43 Smith GN. et al. Effect of intraarticular hyaluronan injection on synovial fluid hyaluronan in the early stage of canine post-traumatic osteoarthritis. J Rheumatol 2001; 28: 1341-6.
    PubMedSuche in Google Scholar
  • 44 Smith GN. et al. Effectof intra-articular hyaluronan injection in experimental canine osteoarthritis. Arthritis Rheum 1998; 41: 976-85.
    CrossrefPubMedSuche in Google Scholar
  • 45 Takahashi K. et al. The effects of hyaluronan on matrix metalloproteinase 3 (MMP3), interlukin 1 beta (IL1 beta), and tissue inhibitor of metalloproteinase 1 (TIMP1) gene expression during the development of osteoarthritis. Osteoarthritis Cartilage 1999; 7: 182-90.
    CrossrefPubMedSuche in Google Scholar
  • 46 Tran-Son-Tay R. et al. Magnetically driven, acoustically tracked, translating-ball rheometer for small, opaque samples. Rev Sci Instrum 1988; 59: 1399-405.
    CrossrefPubMedSuche in Google Scholar
  • 47 Tulamo RM. et al. Concentration and molecular weight distribution of hyaluronate in synovial fluid from clinically normal horses and horses with diseased joints. Am J Vet Res 1994; 55: 710-5.
    PubMedSuche in Google Scholar
  • 48 Tulamo RM. et al. Hyaluronate and large molecular weight proteoglycans in synovial fluid from horses with various arthritides. Am J Vet Res 1996; 57: 932-7.
    PubMedSuche in Google Scholar
  • 49 Uebelhart D. et al. Effects of hyaluronic acid on cartilage degradation. Curr Opin Rheumatol 1999; 11: 427-35.
    CrossrefPubMedSuche in Google Scholar
  • 50 Yasui T. et al. The effect ofhyaluronan on interlukin 1 induced prostaglandin E-2 production in human osteoarthritis synovial cells. Agents Actions 1992; 37: 156-6.
    PubMedSuche in Google Scholar